MDxHealth

Ottergemsesteenweg 460

9000 Gent

BE

MDxHealth

Foundation date

2003

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

MDxHealth is a molecular diagnostics company committed to developing novel, accurate, and informative diagnostic tests for early detection of cancer and for personalizing cancer treatment decisions.

Upcoming events

Latest news

  • Jyseleca®▼ (Filgotinib) licensed for the treatment of adult patients with moderately to severely active ulcerative colitis in Great Britain

    16 hours ago

  • The new Walloon company Cellaïon makes its first closing

    16 hours ago

  • 7 (re)new(ed) strategic partnerships push flanders.bio forward into 2022

    11 hours ago